Evaluation of a novel, sensitive thyroid-stimulating hormone assay as a diagnostic test for thyroid disease in cats
American Journal of Veterinary Research · 2024
DOI: 10.2460/ajvr.23.12.0278 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift American Journal of Veterinary Research, 2024. Verfasst von Mark E Peterson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Animal Endocrine Clinic, New York, NY. Hauptthemen laut MEDLINE: Cat Diseases, Thyrotropin, Sensitivity and Specificity. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE Clinicians commonly use thyroid-stimulating hormone (TSH) concentrations to diagnose thyroid disorders in humans and dogs. In cats, canine TSH chemiluminescent immunoassays (CLIA) assays are commonly used to measure TSH, but these TSH-CLIAs cannot measure low TSH concentrations (< 0.03 ng/mL) and therefore cannot distinguish between low-normal concentrations and truly low TSH concentrations (characteristic of hyperthyroidism). Our aim was to evaluate a novel TSH assay based on bulk acoustic wave (BAW) technology that has lower functional sensitivity (0.008 ng/mL) than TSH-CLIAs. ANIMALS 169 untreated hyperthyroid cats, 53 cats treated with radioiodine ( 131 I), 12 cats with chronic kidney disease (CKD), and 78 clinically healthy cats. METHODS Serum concentrations of T 4 , TSH-CLIA, and TSH-BAW were measured in all cats. Untreated hyperthyroid cats were divided into 4 severity groups (subclinical, mild, moderate, and severe), whereas 131 I-treated cats were divided into euthyroid and hypothyroid groups. RESULTS Test sensitivity, specificity, and positive predictive value for identifying hyperthyroidism were higher for TSH-BAW (90.5%, 98.9%, and 86.9%) than TSH-CLIA (79.9%, 76.7%, and 21.7%; P < .001). Test sensitivity for identifying 131 I-induced hypothyroidism was only 45.5% for T 4 versus 100.0% for both TSH-CLIA and TSH-BAW ( P = .03), whereas TSH-BAW had a higher positive predictive value (100%) than did either TSH-CLIA (81.2%) or T 4 (71.9%). CLINICAL RELEVANCE Serum TSH-BAW alone or together with T 4 is a highly sensitive and specific diagnostic test for evaluating feline hyperthyroidism and iatrogenic hypothyroidism. Finding low serum TSH-BAW concentrations is most useful for diagnosing subclinical and mild hyperthyroidism, in which serum T 4 remains within or only slightly above the reference interval.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Animal Endocrine Clinic, New York, NY.
- College of Veterinary Medicine, Cornell University, Ithaca, NY.
- The Cat Practice, New York, NY.
ORCID-Profile: Mark E Peterson, Mark Rishniw
Zitieren
APA
Peterson, M. E., Dougherty, E., & Rishniw, M. (2024). Evaluation of a novel, sensitive thyroid-stimulating hormone assay as a diagnostic test for thyroid disease in cats. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.23.12.0278
Vancouver
Peterson ME, Dougherty E, Rishniw M. Evaluation of a novel, sensitive thyroid-stimulating hormone assay as a diagnostic test for thyroid disease in cats. American Journal of Veterinary Research. 2024. doi:10.2460/ajvr.23.12.0278
BibTeX
@article{Peterson2024,
author = {Peterson, Mark E and Dougherty, Eric and Rishniw, Mark},
title = {Evaluation of a novel, sensitive thyroid-stimulating hormone assay as a diagnostic test for thyroid disease in cats},
journal = {American Journal of Veterinary Research},
year = {2024},
doi = {10.2460/ajvr.23.12.0278}
}
EUVIMED